![D. Kirkpatrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
D. Kirkpatrick
Directeur Général chez
ENSYSCE BIOSCIENCES, INC.
Fortune : 30 $ au 31/05/2026
Profil
D.
Lynn Kirkpatrick was the founder of ProlX Pharmaceuticals Corp., founded in 1999, serving as President & Chief Executive Officer from 1999 to 2006.
Dr. Kirkpatrick is the founder of Phusis Therapeutics, Inc., founded in 2009.
Dr. Kirkpatrick currently holds the position of President, Chief Executive Officer & Director at Ensysce Biosciences, Inc., starting in 2009.
Former positions include President, Chief Executive Officer & Director at Ensysce Biosciences, Inc., Director at BiologicsMD, Inc., Chief Scientific Officer at Biomira, Inc., Professor at the University of Regina from 1983 to 2001, and Chief Scientific Officer at Cascadian Therapeutics LLC from 2006 to 2008.
Education includes undergraduate and doctorate degrees from the University of Saskatchewan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/11/2025 | 107 ( 0% ) | 30 $ | 31/05/2026 |
Postes actifs de D. Kirkpatrick
| Sociétés | Poste | Début |
|---|---|---|
| ENSYSCE BIOSCIENCES, INC. | Directeur Général | 01/01/2009 |
Anciens postes connus de D. Kirkpatrick
| Sociétés | Poste | Fin |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Directeur Technique/Scientifique/R&D | 31/12/2008 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Directeur Technique/Scientifique/R&D | 11/12/2007 |
ProlX Pharmaceuticals Corp.
 ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Directeur Général | 01/01/2006 |
University of Regina
 University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2001 |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Fondateur | - |
Formation de D. Kirkpatrick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Health Services |
University of Regina
University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
BiologicsMD, Inc.
 BiologicsMD, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical therapeutic development company which focuses on smart therapies for hair loss and bone disorders | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProlX Pharmaceuticals Corp.
ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Health Technology |
Ensysce Biosciences, Inc. /Old/
 Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Supplies drugs for pain and cancer markets | Distribution Services |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Health Technology |
Ensysce Biosciences, Inc.
 Ensysce Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
